Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Magnetic Resonance Imaging Texture Analysis Predicts Recurrence in Patients With Nasopharyngeal Carcinoma.

Raghavan Nair JK, Vallières M, Mascarella MA, El Sabbagh N, Duchatellier CF, Zeitouni A, Shenouda G, Chankowsky J.

Can Assoc Radiol J. 2019 Nov;70(4):394-402. doi: 10.1016/j.carj.2019.06.009. Epub 2019 Sep 11.

PMID:
31519372
2.

Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study.

Eldridge RC, Pugh SL, Trotti A, Hu K, Spencer S, Yom SS, Rosenthal D, Read N, Desai A, Gore E, Shenouda G, Mishra MV, Bruner D, Xiao C.

Head Neck. 2019 Nov;41(11):3924-3932. doi: 10.1002/hed.25922. Epub 2019 Aug 22.

PMID:
31435980
3.

Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer.

Mell LK, Shen H, Nguyen-Tân PF, Rosenthal DI, Zakeri K, Vitzthum LK, Frank SJ, Schiff PB, Trotti AM 3rd, Bonner JA, Jones CU, Yom SS, Thorstad WL, Wong SJ, Shenouda G, Ridge JA, Zhang QE, Le QT.

Clin Cancer Res. 2019 Dec 1;25(23):7078-7088. doi: 10.1158/1078-0432.CCR-19-1832. Epub 2019 Aug 16.

PMID:
31420360
4.

Growth of Pituitary Macroadenomas Postpartial Resection: Implications for Adjuvant Radiotherapy.

Panet-Raymond V, Sabit K, Shenouda G, Sirhan D, Zeitouni A, Souhami L.

J Neurol Surg B Skull Base. 2019 Jun;80(3):323-326. doi: 10.1055/s-0038-1670686. Epub 2018 Oct 10.

PMID:
31143578
5.

Deep learning in head & neck cancer outcome prediction.

Diamant A, Chatterjee A, Vallières M, Shenouda G, Seuntjens J.

Sci Rep. 2019 Feb 26;9(1):2764. doi: 10.1038/s41598-019-39206-1.

6.

Evaluation of supportive and barrier-protective skin care products in the daily prevention and treatment of cutaneous toxicity during systemic chemotherapy.

Lüftner D, Dell'Acqua V, Selle F, Khalil A, Leonardi MC, De La Torre Tomás A, Shenouda G, Romero Fernandez J, Orecchia R, Moyal D, Seité S.

Onco Targets Ther. 2018 Sep 17;11:5865-5872. doi: 10.2147/OTT.S155438. eCollection 2018.

7.

Prognostic factors for progression in atypical meningioma.

Shakir SI, Souhami L, Petrecca K, Mansure JJ, Singh K, Panet-Raymond V, Shenouda G, Al-Odaini AA, Abdulkarim B, Guiot MC.

J Neurosurg. 2018 Nov 1;129(5):1240-1248. doi: 10.3171/2017.6.JNS17120.

PMID:
29350599
8.

Performance of Knowledge-Based Radiation Therapy Planning for the Glioblastoma Disease Site.

Chatterjee A, Serban M, Abdulkarim B, Panet-Raymond V, Souhami L, Shenouda G, Sabri S, Jean-Claude B, Seuntjens J.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):1021-1028. doi: 10.1016/j.ijrobp.2017.07.012. Epub 2017 Jul 14.

PMID:
28870791
9.

Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.

Azoulay M, Santos F, Shenouda G, Petrecca K, Oweida A, Guiot MC, Owen S, Panet-Raymond V, Souhami L, Abdulkarim BS.

J Neurooncol. 2017 May;132(3):419-426. doi: 10.1007/s11060-017-2383-2. Epub 2017 Apr 3.

PMID:
28374095
10.

A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma.

Shenouda G, Souhami L, Petrecca K, Owen S, Panet-Raymond V, Guiot MC, Corredor AG, Abdulkarim B.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):487-494. doi: 10.1016/j.ijrobp.2016.11.006. Epub 2016 Nov 15.

PMID:
28011051
11.

Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical Trial.

Siu LL, Waldron JN, Chen BE, Winquist E, Wright JR, Nabid A, Hay JH, Ringash J, Liu G, Johnson A, Shenouda G, Chasen M, Pearce A, Butler JB, Breen S, Chen EX, FitzGerald TJ, Childs TJ, Montenegro A, O'Sullivan B, Parulekar WR.

JAMA Oncol. 2017 Feb 1;3(2):220-226. doi: 10.1001/jamaoncol.2016.4510.

PMID:
27930762
12.

Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.

Truong MT, Zhang Q, Rosenthal DI, List M, Axelrod R, Sherman E, Weber R, Nguyen-Tân PF, El-Naggar A, Konski A, Galvin J, Schwartz D, Trotti A, Silverman C, Singh A, Godette K, Bonner JA, Jones CU, Garden AS, Shenouda G, Matthiesen C, Le QT, Bruner D.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):687-699. doi: 10.1016/j.ijrobp.2016.08.003. Epub 2016 Aug 12.

13.

Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience.

Bar-Ad V, Zhang QE, Harari PM, Axelrod R, Rosenthal DI, Trotti A, Jones CU, Garden AS, Song G, Foote RL, Raben D, Shenouda G, Spencer SA, Harris J, Le QT.

Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1346-1354. doi: 10.1016/j.ijrobp.2016.03.011. Epub 2016 Mar 26.

14.

Moderate hypofractionated external beam radiotherapy alone for intermediate risk prostate cancer: long term outcomes.

Faria SL, Neto OB, Cury F, Shenouda G, Russel R, Souhami L.

Can J Urol. 2016 Apr;23(2):8209-14.

PMID:
27085825
15.

A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: the McGill University experience.

Al-Wassia R, Vakilian S, Holly C, Sultanem K, Shenouda G.

J Otolaryngol Head Neck Surg. 2015 Sep 2;44:31. doi: 10.1186/s40463-015-0084-4.

16.

Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution.

Azoulay M, Santos F, Souhami L, Panet-Raymond V, Petrecca K, Owen S, Guiot MC, Patyka M, Sabri S, Shenouda G, Abdulkarim B.

Radiat Oncol. 2015 Apr 26;10:106. doi: 10.1186/s13014-015-0396-6.

17.

Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck.

Shenouda G, Zhang Q, Ang KK, Machtay M, Parliament MB, Hershock D, Suntharalingam M, Lin A, Rotman M, Nabid A, Hong S, Shehata S, Cmelak AJ, Sultanem K, Le QT.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):907-15. doi: 10.1016/j.ijrobp.2014.12.018. Epub 2015 Feb 7.

18.

p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.

Chung CH, Zhang Q, Kong CS, Harris J, Fertig EJ, Harari PM, Wang D, Redmond KP, Shenouda G, Trotti A, Raben D, Gillison ML, Jordan RC, Le QT.

J Clin Oncol. 2014 Dec 10;32(35):3930-8. doi: 10.1200/JCO.2013.54.5228. Epub 2014 Sep 29.

19.

A case of recurrent anaplastic meningioma of the skull base with radiologic response to hydroxyurea.

Gurberg J, Bouganim N, Shenouda G, Zeitouni A.

J Neurol Surg Rep. 2014 Aug;75(1):e52-5. doi: 10.1055/s-0033-1359300. Epub 2014 Apr 17.

20.

Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer.

Beitler JJ, Zhang Q, Fu KK, Trotti A, Spencer SA, Jones CU, Garden AS, Shenouda G, Harris J, Ang KK.

Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):13-20. doi: 10.1016/j.ijrobp.2013.12.027. Epub 2014 Mar 7.

21.

Intraoperative sonographically assisted radioactive iodine 125 plaque brachytherapy for choroidal melanoma: visual acuity outcome.

Quinlan-Davidson S, AlMahmoud T, Shenouda G, Evans M, Mansour M, Edelstein C, Pond G, Deschênes J.

J Ultrasound Med. 2013 Jun;32(6):995-1001. doi: 10.7863/ultra.32.6.995.

PMID:
23716521
22.

Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes.

Patel N, Faria S, Cury F, David M, Duclos M, Shenouda G, Ruo R, Souhami L.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):534-9. doi: 10.1016/j.ijrobp.2013.02.010. Epub 2013 Apr 15.

PMID:
23597418
23.

Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer - long term results.

Cury FL, Duclos M, Aprikian A, Patrocinio H, Kassouf W, Shenouda G, Faria S, David M, Souhami L.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1417-23. doi: 10.1016/j.ijrobp.2011.05.025. Epub 2011 Jul 23.

PMID:
21784585
24.

Stereotactic fractionated radiotherapy in the treatment of juxtapapillary choroidal melanoma: the McGill University experience.

Al-Wassia R, Dal Pra A, Shun K, Shaban A, Corriveau C, Edelstein C, Deschenes J, Ruo R, Patrocinio H, Cury FL, DeBlois F, Shenouda G.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e455-62. doi: 10.1016/j.ijrobp.2011.05.012. Epub 2011 Jun 25.

PMID:
21708428
25.

Consent to external-beam radiotherapy.

Freeman C, Lamed H, Gingras C, Shenouda G.

Curr Oncol. 2010 Nov;17(6):9-11.

26.

Hypofractionated radiotherapy for favorable risk prostate cancer.

Rene N, Faria S, Cury F, David M, Duclos M, Shenouda G, Souhami L.

Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):805-10. doi: 10.1016/j.ijrobp.2009.05.047.

PMID:
20510194
27.

Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas.

Elhateer H, Muanza T, Roberge D, Ruo R, Eldebawy E, Lambert C, Patrocinio H, Shenouda G, Souhami L.

Curr Oncol. 2008 Dec;15(6):286-92.

28.

Iodine-125 radiotherapy for choroidal melanoma.

Al Mahmoud T, Mansour M, Deschênes J, Edelstein C, Burnier M, Marcil M, Shenouda G, Corriveau C, Evans M.

Ann N Y Acad Sci. 2008 Sep;1138:15-8. doi: 10.1196/annals.1414.003.

PMID:
18837877
29.

Intra-operative echographic localization for radioactive ophthalmic plaques in choroidal melanoma.

Al Mahmoud T, Mansour M, Deschênes J, Edelstein C, Burnier M, Marcil M, Shenouda G, Corriveau C, Evans M.

Ann N Y Acad Sci. 2008 Sep;1138:10-4. doi: 10.1196/annals.1414.002.

PMID:
18837876
30.

Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.

Panet-Raymond V, Souhami L, Roberge D, Kavan P, Shakibnia L, Muanza T, Lambert C, Leblanc R, Del Maestro R, Guiot MC, Shenouda G.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):473-8. doi: 10.1016/j.ijrobp.2008.04.030. Epub 2008 Jun 12.

PMID:
18554821
31.

Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).

Machtay M, Pajak TF, Suntharalingam M, Shenouda G, Hershock D, Stripp DC, Cmelak AJ, Schulsinger A, Fu KK; Radiation Therapy Oncology Group.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1008-17. Epub 2007 Aug 23.

PMID:
17716826
33.

Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection?

Aslani M, Sultanem K, Voung T, Hier M, Niazi T, Shenouda G.

Head Neck. 2007 Jun;29(6):585-90.

PMID:
17274051
34.

An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound localizations.

Poli ME, Parker W, Patrocinio H, Souhami L, Shenouda G, Campos LL, Podgorsak EB.

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1430-7. Epub 2007 Jan 8.

PMID:
17208385
35.

Ultrasound-based image guided radiotherapy for prostate cancer: comparison of cross-modality and intramodality methods for daily localization during external beam radiotherapy.

Cury FL, Shenouda G, Souhami L, Duclos M, Faria SL, David M, Verhaegen F, Corns R, Falco T.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1562-7. Epub 2006 Oct 23.

PMID:
17056194
36.

Is there a detrimental effect of waiting for radiotherapy for patients with localized prostate cancer?

Faria SL, Mahmud S, Wakil G, Negrete S, Souhami L, David M, Duclos M, Shenouda G, Freeman CR.

Am J Clin Oncol. 2006 Oct;29(5):463-7.

PMID:
17023780
37.

Erythropoietin receptor expression in biopsy specimens from patients with uterine cervix squamous cell carcinoma.

Shenouda G, Mehio A, Souhami L, Duclos M, Portelance L, Belenkov A, Chow T.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):752-6.

PMID:
16681756
38.

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.

Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, Winn R, Pajak TF, Williams B, Shenouda G, Hodson I, Fu K, Shin DM, Vokes EE, Feng L, Goepfert H, Hong WK.

J Natl Cancer Inst. 2006 Apr 5;98(7):441-50.

PMID:
16595780
39.

No immediate treatment after biochemical failure in patients with prostate cancer treated by external beam radiotherapy.

Faria SL, Mahmud S, Souhami L, David M, Duclos M, Shenouda G, Makis W, Freeman CR.

Urology. 2006 Jan;67(1):142-6.

PMID:
16413350
40.

Intermittent androgen ablation in patients with biochemical failure after pelvic radiotherapy for localized prostate cancer.

Cury FL, Souhami L, Rajan R, Tanguay S, Gagnon B, Duclos M, Shenouda G, Faria SL, David M, Freeman CR.

Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):842-8. Epub 2005 Nov 14.

PMID:
16289909
41.

Energy modulated electron therapy using a few leaf electron collimator in combination with IMRT and 3D-CRT: Monte Carlo-based planning and dosimetric evaluation.

Al-Yahya K, Schwartz M, Shenouda G, Verhaegen F, Freeman C, Seuntjens J.

Med Phys. 2005 Sep;32(9):2976-86.

PMID:
16266112
42.

Long-term results of para-aortic irradiation for patients with stage I seminoma of the testis.

Niazi TM, Souhami L, Sultanem K, Duclos M, Shenouda G, Freeman C.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):741-4.

PMID:
15708252
43.

Treatment of medium-sized juxtapapillary melanoma with external Co-60 photon therapy.

Roberge D, Nordstrom S, Corriveau C, Gosselin M, Olivares M, Shenouda G.

Radiother Oncol. 2005 Jan;74(1):71-3.

PMID:
15683673
44.

Biochemical failure as single abnormality in patients with prostate cancer following radical treatment with external radiotherapy: follow-up without immediate treatment.

Faria SL, Salah M, David M, Souhami L, Duclos M, Shenouda G, Deblois F, Janick C, Freeman CR.

Int Braz J Urol. 2004 Jul-Aug;30(4):289-95; discussion 295.

45.

Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin.

Belenkov AI, Shenouda G, Rizhevskaya E, Cournoyer D, Belzile JP, Souhami L, Devic S, Chow TY.

Mol Cancer Ther. 2004 Dec;3(12):1525-32.

46.

Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer.

Gornitsky M, Shenouda G, Sultanem K, Katz H, Hier M, Black M, Velly AM.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Jul;98(1):45-52.

PMID:
15243470
47.

Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum.

Vuong T, Franco E, Lehnert S, Lambert C, Portelance L, Nasr E, Faria S, Hay J, Larsson S, Shenouda G, Souhami L, Wong F, Freeman C.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):809-14.

PMID:
15183484
48.

The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.

Sultanem K, Patrocinio H, Lambert C, Corns R, Leblanc R, Parker W, Shenouda G, Souhami L.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):247-52.

PMID:
14697445
49.

Safety of a simple asymmetric jaw technique in the treatment of head and neck cancer.

Roberge D, Gosselin M, Sultanem K, Corns R, Shenouda G.

Radiother Oncol. 2003 Aug;68(2):149-52.

PMID:
12972309
50.

Inducible nitric oxide synthase and nitrotyrosine in mice with radiation-induced lung damage.

Giaid A, Lehnert SM, Chehayeb B, Chehayeb D, Kaplan I, Shenouda G.

Am J Clin Oncol. 2003 Aug;26(4):e67-72.

PMID:
12902901

Supplemental Content

Loading ...
Support Center